Login / Signup

The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients.

Chien-Wei PengWen-Juei Jeng
Published in: Hepatology international (2021)
Keyphrases
  • hepatitis b virus
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • stem cells
  • patient reported outcomes
  • bone marrow